G62D (p.Gly62Asp) variant of CYP2C9 (Cytochrome P450 2C9)
G62D (p.Gly62Asp) in CYP2C9 (Cytochrome P450 2C9) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.57 / 1. The record also includes population frequency data and structural context.
G62D (p.Gly62Asp) variant details
- p.Gly62Asp
- rs867193471
- NCI-TCGA Cosmic COSV5324
- gnomAD rs867193471
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.571
- REVEL 0.55
- CADD 24.90
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the African/African-American population (allele frequency 2.4e-05)
- Structural context available